Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Gene Therapy
Research on cancer gene therapy detailed by scientists at Sun Yat-Sen University, Cancer Center
February 27th, 2007
Data detailed in "Centromere protein H is a novel prognostic marker for nasopharyngeal carcinoma progression and overall patient survival" have been presented. "The aim of the present study was to analyze the expression of Centromere protein H (CENP-H), one of the fundamental components of the human active kinetochore, in nasopharyngeal carcinoma (NPC) and to correlate it with clinicopathologic data, including patient survival. Using reverse transcription-PCR and Western blot, we detected the expression of CENP-H in normal nasopharyngeal epithelial cells, immortalized nasopharyngeal epithelial cell lines, and NPC cell lines," scientists writing in the journal Clinical Cancer...
Source: Cancer Weekly (2007-02-27)
|
